You are in the accessibility menu

Statistics

Total Visits

Views
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1 237

Total Visits per Month

September 2025 October 2025 November 2025 December 2025 January 2026 February 2026 March 2026
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1 21 17 19 6 2 4 6

File Downloads

Views

Top Country Views

Views
United States 94
Brazil 33
Germany 24
Vietnam 10
China 8
Russia 8
Ukraine 7
Turkey 4
Argentina 3
United Kingdom 3

Top City Views

Views
Ashburn 17
San Mateo 16
Hanoi 8
Fairfield 7
Cambridge 6
Jacksonville 5
Seattle 3
Tokyo 3
Ho Chi Minh City 2
Korolëv 2